Ben May Department for Cancer Research and the College
Lixing Yang is a computational biologist whose research focuses on integrating large-scale high-throughput sequencing data to study the genomic alterations of human cancer in order to detect novel disease-driving alterations and drug targets. He is particularly interested in large-scale genomic rearrangements that lead to structural changes of patient DNA. His group is actively developing new computational algorithms to better detect genomic alterations, to understand mutational mechanisms, and to model disease progression.
His work has been published in leading scientific journals, including the American Journal of Human Genetics, Cell, Nature, Science, and the New England Journal of Medicine.
Yang obtained a BS in biology from Fudan University in China, followed by an MS in statistics and a PhD in genetics from the University of Georgia. He completed his postdoctoral training at Harvard Medical School. He also holds an appointment at the University of Chicago’s Institute for Genomics and Systems Biology.